These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25761680)

  • 1. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.
    Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA
    Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase inhibition, oligonucleotides, and clinical trials.
    Corey DR
    Oncogene; 2002 Jan; 21(4):631-7. PubMed ID: 11850789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of telomerase activity by preventing proper assemblage.
    Keppler BR; Jarstfer MB
    Biochemistry; 2004 Jan; 43(2):334-43. PubMed ID: 14717587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
    Ozawa T; Gryaznov SM; Hu LJ; Pongracz K; Santos RA; Bollen AW; Lamborn KR; Deen DF
    Neuro Oncol; 2004 Jul; 6(3):218-26. PubMed ID: 15279714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anticancer therapeutics targeting telomerase.
    Ruden M; Puri N
    Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [siRNA targeting telomerase--effective tool in anti-cancer therapy?].
    Rubiś B; Półrolniczak A; Rybczyńska M
    Postepy Biochem; 2008; 54(4):384-92. PubMed ID: 19248585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibitors in cancer therapy: current status and future directions.
    Incles CM; Schultes CM; Neidle S
    Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase: a target for cancer therapeutics.
    Shay JW; Wright WE
    Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
    Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
    Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Telomeres and telomerase as targeted therapies in cancer treatment].
    Souiden Y; Bouraoui A; Chaieb K; Mahdouani K
    Bull Cancer; 2010 Sep; 97(9):1087-104. PubMed ID: 20663741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent patents on anti-telomerase cancer therapy.
    Agrawal A; Dang S; Gabrani R
    Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):102-17. PubMed ID: 21854360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.
    Pruzan R; Pongracz K; Gietzen K; Wallweber G; Gryaznov S
    Nucleic Acids Res; 2002 Jan; 30(2):559-68. PubMed ID: 11788719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.